Home > Tocilizumab Reduces Risk Of Death In Severe COVID-19 Patients

News
Tocilizumab Reduces Risk Of Death In Severe COVID-19 Patients

Description

Treatment with the drug tocilizumab has been shown to reduce the risk of death among hospitalized patients with severe COVID-19. Tocilizumab cuts the risk of death by about 30%, according to a study published Tuesday. The medication, which also goes by the name Actmera is primarily used to treat rheumatoid arthritis. The medication is an immunosuppressive drug designed to reduce inflammation. It also works to suppress interleukin 6, a type of protein involved in the inflammatory process in a number of diseases, including COVID-19.

Added on the 21/10/2020 20:54:04 - Copyright : Wochit

To customise your video :

Or Create an account

More videos on the subject

More videosNews

Watch video of  - DemainEntreprendre - épisode 12 - Label : Economie wallonne -
News

DemainEntreprendre - épisode 12

29/04/2021 12:55:32